인쇄하기
취소
|
As the Korean Medical Association uses the Valsartan case as a reason to oppose to introduction of the international proprietary names, the Korean Pharmaceutical Association criticized that the medical association was trying to deceive the entire nation.
The Korean Pharmaceutical Association refuted the medical association’s argument in the statement on the 10th, saying “This incident was caus...